Tätä mahdollisuutta ei voida kuitenkaan täysin poissulkea. ###>Based on the metabolic profiles, a clinically relevant drug interaction would not be expected with other specific inhibitors of CYP3A (e.g., fluconazole, itraconazole, clarithromycin, erythromycin); however, the possibility cannot be excluded.